[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338662-105":59,"doc-detail-338662-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","predictive-value-of-a-gastric-microbiota-dysbiosis-test-for-stratifying-cancer-risk-in-atrophic-gastritis-patients-research-paper","Predictive Value of a Gastric Microbiota Dysbiosis Test for Stratifying Cancer Risk in Atrophic Gastritis Patients - Research Paper","","Gastric cancer incidence stays high worldwide while outcomes remain poor, and development proceeds from atrophic gastritis through intestinal metaplasia and dysplasia. Because Helicobacter pylori eradication does not eliminate cancer risk, this work targets Helicobacter pylori–negative atrophic gastritis patients, comparing those with high-grade dysplasia or gastric cancer to those with atrophic gastritis only. Microbiota composition is profiled by 16S rRNA sequencing of antrum and corpus biopsies. A multiparametric resident gastric microbiota dysbiosis test (RGM-DT) is proposed, showing 88.9% specificity for discriminating progression risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/predictive-value-of-a-gastric-microbiota-dysbiosis-test-for-stratifying-cancer-risk-in-atrophic-gastritis-patients-research-paper/338662/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/predictive-value-of-a-gastric-microbiota-dysbiosis-test-for-stratifying-cancer-risk-in-atrophic-gastritis-patients-research-paper/338662.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What patient population is studied in the article?","Question",{"text":112,"@type":113},"Consecutive patients undergoing upper endoscopy during endoscopic follow-up for atrophic gastritis are included, focusing on Helicobacter pylori–negative individuals with either high-grade dysplasia/gastric cancer or atrophic gastritis only.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is the gastric microbiota assessed?",{"text":117,"@type":113},"Gastric antrum and corpus biopsies are used, and microbiota composition is evaluated by sequencing the 16S ribosomal RNA gene.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the main performance outcome reported for the proposed test?",{"text":121,"@type":113},"The Resident Gastric Microbiota Dysbiosis Test (RGM-DT) demonstrates 88.9% specificity in discriminating patients with high-grade dysplasia/gastric cancer from those with atrophic gastritis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338662,1790740335,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Article  \nPredictive Value of a Gastric Microbiota Dysbiosis Test for Stratifying Cancer Risk in Atrophic Gastritis Patients  \nAlice Zaramella 1,2, Diletta Arcidiacono 2, Miriam Duci 3,4, Clara Benna 1, Salvatore Pucciarelli 1, Alberto Fantin 2, Antonio Rosato 1,5, Valli De Re 6, Renato Cannizzaro 7,8, Matteo Fassan 9,10 and Stefano Realdon 7, *  \nAcademic Editor: Le Ma  \nReceived: 3 December 2024  \nRevised: 24 December 2024  \nAccepted: 29 December 2024  \nPublished: 31 December 2024  \nCitation: Zaramella, A.; Arcidiacono, D.; Duci, M.; Benna, C.; Pucciarelli, S.; Fantin, A.; Rosato, A.; De Re, V.; Cannizzaro, R.; Fassan, M.; et al. Predictive Value of a Gastric Microbiota Dysbiosis Test for Stratifying Cancer Risk in Atrophic Gastritis Patients. Nutrients 2025, 17, 142. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)nu17010142  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2,  \n35128 Padua, Italy; [alice.zaramella@unipd.it](alice.zaramella@unipd.it) (A.Z.); [clara.benna@unipd.it](clara.benna@unipd.it) (C.B.); [puc@unipd.it](puc@unipd.it) (S.P.);  \n[antonio.rosato@iov.veneto.it](antonio.rosato@iov.veneto.it) (A.R.)  \n2 Gastroenterology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy; [diletta.arcidiacono@iov.veneto.it](diletta.arcidiacono@iov.veneto.it) (D.A.); [alberto.fantin@iov.veneto.it](alberto.fantin@iov.veneto.it) (A.F.)  \n3 Department of Women’s and Children’s Health, University of Padova, 35128 Padova, Italy; [ducimiriam@gmail.com](ducimiriam@gmail.com)  \n4 Pediatric Surgery Unit, Division of Women’s and Children’s Health, Padova University Hospital,  \n35128 Padova, Italy  \n5 UOC Immunology and Molecular Oncology, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy  \n6 Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano, National Cancer Institute, IRCCS, 33081 Aviano, Italy; vdere@cro.it  \n7 Oncological Gastroenterology, Centro di Riferimento Oncologico di Aviano (CRO), National Cancer Institute, IRCCS, 33081 Aviano, Italy; [rcannizzaro@cro.it](rcannizzaro@cro.it)  \n8 Department of Medical, Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy  \n9 Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy; matteo.fassan@unipd.it  \n10 Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, Via Gabelli 61,  \n35121 Padua, Italy  \n* Correspondence: [stefano.realdon@cro.it](stefano.realdon@cro.it)  \nAbstract: Background/Objectives: Gastric cancer (GC) incidence remains high worldwide, and the survival rate is poor. GC develops from atrophic gastritis (AG), associated with Helicobacter pylori (Hp) infection, passing through intestinal metaplasia and dysplasia steps. Since Hp eradication does not exclude GC development, further investigations are needed. New data suggest the possible role of unexplored gastric microbiota beyond Hp in the progression from AG to GC. Aimed to develop a score that could be used in clinical practice to stratify GC progression risk, here was investigate gastric microbiota in AG Hp-negative patients with or without high-grade dysplasia (HGD) or GC. Methods: Consecutive patients undergoing upper endoscopy within an endoscopic follow-up for AG were considered. The antrum and corpus biopsies were used to assess the microbiota composition along the disease progression by sequencing the 16S ribosomal RNA gene. Statistical differences between HGD/GC and AG patients were included in a multivariate analysis. Results: HGD/GC patients","cbCaisGQnwOHsDlc","https://ap.wps.com/l/cbCaisGQnwOHsDlc","pdf",11776990,18,"English","# Abstract\n# Introduction\n## Gastric cancer burden and progression\n## Helicobacter pylori and additional risk factors\n# Materials and Methods\n# Results\n# Conclusions","[{\"question\":\"What patient population is studied in the article?\",\"answer\":\"Consecutive patients undergoing upper endoscopy during endoscopic follow-up for atrophic gastritis are included, focusing on Helicobacter pylori–negative individuals with either high-grade dysplasia/gastric cancer or atrophic gastritis only.\"},{\"question\":\"How is the gastric microbiota assessed?\",\"answer\":\"Gastric antrum and corpus biopsies are used, and microbiota composition is evaluated by sequencing the 16S ribosomal RNA gene.\"},{\"question\":\"What is the main performance outcome reported for the proposed test?\",\"answer\":\"The Resident Gastric Microbiota Dysbiosis Test (RGM-DT) demonstrates 88.9% specificity in discriminating patients with high-grade dysplasia/gastric cancer from those with atrophic gastritis.\"}]","Predictive Value of a Gastric Microbiota Dysbiosis Test for Stratifying Cancer Risk in Atrophic Gastritis Patients - Research Paper | PDF",1790024907,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6248da25945c877bad2c597607f4c76.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85dc9cc4d59e31f6a73ec748aac8c7f3.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99c09f6106a5e5ad8cc4f94d55845cd1.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9db7e3fe0298c22ca09d64a46a8b72a.webp",980,1385]